Abstract

A9-dopaminergic phenotype, 2083
Active caspase 3, 1381
Acute kidney injury (AKI), 517
Acute liver failure after massive hepatectomy, 1547
Acute myocardial infarction (AMI), 1645
Acute respiratory distress syndrome (ARDS), 1635
4-[18F]-ADAM, 301
Adhesion, 1265
Adiponectin (APN), 2051
Adipose, 109
Adipose-derived adult stem cells (ADSCs), 559
Adipose-derived mesenchymal stem cells (ADSCs), 261, 1193
Adipose-derived stem cells (ADSCs/ASCs), 71, 899, 1609, 1635, 2017
Adipose tissue-derived mesenchymal stem cells (ASCs), 243
Adipose tissue-derived stem cells (ADSCs), 1177
Adoptive transfer, 811
Adult neurogenesis, 1979
Advanced therapy medicinal products (ATMPs), 437
Aggregate, 1343
Aging, 705
Allele-specific silencing, 677
Allogeneic bone marrow mesenchymal stem cells (allo-BMSCs), 229
Allogeneic myeloid progenitors, 17
Alloimmune monitoring, 2259
Alternative medicine, 621
Alveolar epithelium injury, 1561
Alzheimer's disease (AD), 687, 1853
Amniotic fluid stem cell, 615
Amniotic membrane (AM), 2245
Amyloid, 481
Amyloid-β (Aβ), 1853
Amyloid-β protein precursor, 687
Amyloidosis (AL), 995
Analgesia, 621
Angiogenesis, 283, 313, 735, 1145, 1665, 2157
Angioprotection, 715
Animal model, 109, 783
Annulus fibrosis (AF), 1819
Anti-HLA antibody, 2041
Anti-inflammatory, 1207
Antioxidant, 883
Apelin-13, 1645
Apoptosis, 261, 343
Arthritis, 2063
Artificial cerebral spinal fluid (aCSF), 645
Astrocytes, 293
Astrotactin 1 (Astn1), 973
Autoimmune, 2063
Autoimmune disease, 243
Autoimmunity, 1, 963, 1575
Autologous keratinocytes, 437
Autologous stem cell transplantation, 615
Autologous transplantation, 141
Autotransplantation, 951
β-Cell mass, 491
β-cells, 1893
bFGF, 2173
Bile duct ligation (BDL), 2245
Biodistribution, 195, 2199
Bladder dysfunction, 125
Bladder epithelium, 425
Blood–brain barrier (BBB), 1453
Bone marrow, 313, 1675
Bone marrow-derived mesenchymal stem cells (BM-MSCs), 2173
Bone marrow-derived stem cells (BMSCs), 1911, 2187
Bone marrow mononuclear cells (BM-MNCs), 983
Bone marrow stromal cells, (BMSCs), 125
Bone tissue engineering, 229
Bowel, 1723
Brain, 645
Brain-derived neurotrophic factor (BDNF), 2129
Burns, 201, 437
Canine, 1415
Cardiac extracellular matrix, 1653
Cardiac progenitor cells (CPCs), 35, 1653
Cardiac regeneration, 1653
Cardiac repair, 929
Cardiac tissue engineering, 1653
Cartilage, 937
Cartilage defects, 1043
Cartilage regeneration, 449
Caspase, 963
Cavernous never injury, 1987
CD11b stem cells, 1665
Cell banking, 463
Cell cycle, 377
Cell delivery, 2213
Cell delivery system, 1073
Cell differentiation, 1879
Cell doubling time, 2099
Cell encapsulation, 2213
Cell grafting, 125
Cell injection, 425
Cell proliferation, 2259
Cell sheet, 549, 1525
Cell suspension, 645
Cell therapy, 109, 201, 849, 1159, 1461, 1609, 1675, 1833, 1911, 1945, 2157, 2199
Cell tracking, 575, 1787, 2199
Cell transplantation, 183, 283, 401, 645, 665, 893, 1115, 1131, 1525, 1713
Cellular drug delivery system, 159
Cellular reprogramming, 1007
Central pattern generator, 1925
Cerebral infarction, 2173
Cerebral ischemia, 1453, 2157
Chemically defined medium, 1501
Chemokines, 503
Chemotaxis, 1265
Chimerism, 1277
Chitosan, 159
Chitosan/silk fibroin scaffold, 983
2-(1-Chloro-4-hydroxyisoquinoline-3-carboxamido) acetic acid (BIC), 35
Chondrocyte(s), 937, 449
Chronic, functional recovery, 141
Chronic pain, 629
Chronic stroke, 729
Circadian rhythm, 275
Clinical islet transplantation, 2269
Clinical relevance, 1073
Clinical trials, 829
Coagulation, 1227
Coencapsulation, 1299
Cognitive impairment, 2129
Cold storage, 531
Collagen-induced arthritis, 243
Complement, 1227
Complement cascade (ComC), 275
Complement inhibitors, 2027
Concentration of fetal bovine serum (FBS), 1025
Conditioned medium, 517
Cord blood (CB), 1501
Cord blood-derived mesenchymal stromal cells (CB-MSCs), 1501
Corneal endothelium, 1159
Coronary sinus, 1713
Corticosterone (CORT), 1979
Critical limb ischemia (CLI), 1623
Cryopreservation, 1247
CTLA4Ig, 243, 1193
Cyclin-dependent kinase inhibitor 1A (CDKN1A), 1489
Cystathionase, 55
Cystitis, 425
Cytokines, 2051
Cytoprotection, 735
Decidual stromal cells (DSCs), 401
Delayed platelet engraftment, 1259
Dementia, 883
Dendritic cells (DCs), 1207
Dental pulp stem cells (DPSCs), 425
Device design, 2213
Diabetes, 481, 1319, 1763, 1879, 2259
Diabetes immunology, 609
Diabetic neuropathy (DN), 313
Diabetic wound healing, 71
Differentially expressed genes (DEGs), 377
Differentiation, 97, 411, 829, 1343, 1833, 2221
Digital image analysis (DIA), 1747, 2245
Digital imaging, 1219
Dimethyl sulfoxide (DMSO), 1247
Dimethyloxaloylglycine (DMOG), 35
Dispersed phase, 645
Dispersion medium, 645
Diurnal rhythm, 275
A9-dopaminergic phenotype, 2083
Double blind, 141
Drug-free, 621
Ear perichondrium-derived cartilage progenitor cells, 951
Ecoimmunity, 1575
Ectopic implantation, 229
Efavirenz (EFV), 1967
Electrical stimulation (ES), 1177
Electrophysiology, 2083
ELISA, 2245
ELISpot, 2259
Embryonic stem cells (ESCs), 97, 1879
Encapsulation devices, 609
Endogenous cardiac stem cells (eCSCs) or progenitors, 1645
Endothelial progenitor cells (EPCs), 365, 735, 2187
Engraftment, 481, 1277
Enriched environment, 863
Enumeration of islets, 2145
Epithelial cells, 437
Eplet, 2041
Erectile dysfunction (ED), 1987
Ex vivo expansion, 17
Exogenous neuronal relay, 1425
Experimental immunotherapy, 811
External magnetic device, 1073
(NZB × NZW) F1 mice, 1193
Factor IX (FIX), 1237
Ferritin, 575
Fetal cartilage-derived progenitor cells (FCPCs), 449
Fetal cell therapy, 463
Fibrinogen, 729
Fibroblast(s), 365, 1525
Fibroblast growth factor 2 (FGF-2), 159, 1359
Fifth component (C5), 275
Fluoro-Gold, 1381
Follicular helper T (Tfh) cells, 1
Fracture, 1801
Functional recovery, 1423
GABA, 629
Ganglionic eminence, 665
Gene expression, 1159
Gene therapy, 677, 1591, 1609
Genetic modification, 811
Glial cell line-derived neurotrophic factor (GNDF), 159
Glioblastoma, 2099
Glioma, 2099
Glucagon-like peptide-1 (GLP-1), 1893
Glucose toxicity, 83
L-Glutamine, 531
Graft dysfunction, 83
Graft survival, 1319
Graft-versus-host disease (GvHD), 1277
Granuloctye-colony stimulating factor (G-CSF), 283, 729 Growth factors, 1115
Guinea pig model, 1405
Hair follicle (HF), 377, 2071
Hair follicle niche, 1439
Hair follicle stem cells (HFSCs), 2071
Hair growth, 1439
Heart failure (HF), 55, 1665, 1675, 1689, 1713
Heat shock protein (HSP), 2099
Hematopoietic cell transplantation, 995
Hematopoietic growth factor, 729, 863
Hematopoietic recovery, 1265
Hematopoietic stem cells, 275
Hematopoietic stem/progenitor cells (HSPCs), 1247
Heme oxygenase 1 (HO-1), 1265
Hemophilia B (HB), 1237
Hepatocytes, 549, 2221
Hepatocyte transdifferentiation, 1893
Hepatocyte transplantation (HT), 1227
Hindlimb dysfunction, 1381
Hippocampal organotypic slice culture, 715
Histocompatibility locus antigen-G, 217
Histone deacetylase inhibitor, 1207
HLA, 1277
Homeostatic model assessment (HOMA), 491
Homing, 1247
Horse, 109, 2003
Human bone marrow, 1405
Human corneal endothelial cells (HCEnC), 1159
Human islet culture, 1539
Human islets, 491
Human mesenchymal stromal cells (hMSCs), 1405
Human neural stem cells (hNSCs), 2083
Human neuroprogenitor cells (hNPCs), 1085
Human parthenogenetic stem cells (hpSCs), 1945
Human umbilical cord blood cells (HUCBSs), 195
Human umbilical cord blood plasma (hUCBP), 963
Humoral immune response, 2027
Huntington's disease (HD), 665, 677
HypoThermosol, 645
Hypoxia, 1539, 2269
Hypoxia-inducible factor (HIF), 35
Hypoxia–reoxygenation (H/R), 517
Hypoxic preconditioning, 35, 797
Image processing, 2145
Image segmentation, 2145
Immature platelet fraction (IPF), 1259
Immune modulation, 1057
Immune response, 1473
Immunogenicity, 229
Immunohistochemistry, 2245
Immunomodulation, 201, 829, 1863
Immunosuppression, 217
Indoleamine 2,3-dioxygenase (IDO), 2051
Induced pluripotent stem cell-derived neural progenitor cells (iPSC-NPCs), 797
Induced pluripotent stem cells (iPSCs), 411, 517, 783, 893, 1237, 1591, 1833, 2003, 2221
Infant, 1131
Infection, 17
Inflammation, 621, 687, 1319, 1539
Inflammatory bowel disease (IBD), 401
Injectable autologous active scaffold, 1043
Innate immunity, 503, 1227
Instant blood-mediated inflammatory reaction (IBMIR), 503
Insulin, 343
Insulin-like growth factor-1 (IGF-1) overexpression, 1609
Insulin-producing cells, 1879
Insulin therapy, 83
Intervertebral disc degeneration, 1819
Intra-arterial, 401
Intramedullary tumor, 2099
Intraparenchymal administration, 1787
Intrathecal transplantation, 593
Intraventricular hemorrhage (IVH), 1131
In utero, 615
In vitro, 1043
Ischemia, 531, 735, 1473
Ischemia–reperfusion (I/R), 517
Ischemia–reperfusion injury, 2129
Ischemic cardiomyopathy (ICM), 1665, 1675, 1911
Ischemic dilated cardiomyopathy (IDCM), 1689
Ischemic stroke, 913
Islet characterization, 1747
Islet culture, 343, 1763
Islet density, 491
Islet endothelial cells (IECs), 97
Islet isolation, 539, 1515, 2269
Islet macroencapsulation, 1539
Islets, 1219, 1525
Islet size, 491
Islet transplantation, 83, 343, 481, 503, 539, 1319, 1331, 1515, 1763, 1777, 2041, 2145, 2259
Islet viability, 1777
Islet volume, 491
Islet xenograft, 327
Islets of Langerhans, 1747
Ixmyelocel-T, 1689
Juveniles, 797
Keratinocyte, 353
Kidney, 1007
Kidney transplant, 995
Kidney transplantation, 1331
Lamina propria, 141
Lentivirus, 1177
L-Glutamine, 531
Ligustilide, 899
Lineage reprogramming, 1893
Lipoaspirate, 1043
Lipopolysaccharide (LPS), 1561
Lithium, 1925
Liver, 849
Liver cell transplantation, 1547
Liver nonparenchymal cells, 1547
Lymph node, 1007
Lymphocytes, 1575
Machine learning, 2145
Macrophages, 1461
Magnetic resonance imaging (MRI), 575, 1787
Magnetic stem cell retention, 1085
Magnetic stimulation, 863
Magnetically labeled mesenchymal stem cells (m-MSCs), 1073
Major histocompatibility complex (MHC) class I, 1575
Mandibular bone defect, 229
Manufacturing, 1219
Megakaryocytes, 1259
Megakaryocytopoiesis, 261
Melatonin receptors, 883
Melatonin, 883
Mesenchymal stem cell (MSC) sheet, 1801
Mesenchymal stem cells (MSCs), 1, 109, 217, 313, 449, 687, 829, 849, 937, 1057, 1101, 1115, 1131, 1145, 1287, 1299, 1423, 1489, 1561, 1591, 1623, 1787, 1801, 1819, 2157
Mesenchymal stromal cells (MSCs), 201, 929, 1415, 1501, 1723, 2063, 2199
Mesenteric cell transplantation, 1547
Metabolic support, 549
Mice, 195
Microcarrier (MC), 1343
Microglia, 1863
Microglial activation, 2111
Microneedle stimulation, 1853
Microvasculature, 2157
Middle cerebral artery occlusion, 705
Middle ear surgery, 1405
Migration, 973
miRNA-20a, 1489
miR-sc3, 973
Miscarriage, 2187
Mitochondria, 913
Mitochondria transfer, 913
Mixed chimerism, 1331
Mixed lymphocyte reaction, 217
Mobilized dental pulp stem cells (MDPSCs), 183
Monkey, 951
Monoclonal antibody (mAb), 327
Mononuclear cells, 1925
Motor deficits, 665
Mouse, 811
Multiple molecular penumbra, 893
Multiple myeloma (MM), 995
Multiple sclerosis, 1207
Muscle, 849
Muscle regeneration, 2003
Muscle regeneration therapy, 2017
Myelin, 411
Myelination, 313
Myoblast, 55
Myocardial infarction (MI), 929, 1609
Myocardial ischemia, 1701
MyoD, 2017
Myogenic differentiation, 2017
Neonatal porcine islets (NPIs), 539
Nephritis, 1
Nerve injury, 1395
Nerve regeneration, 1425
Neural differentiation, 1423
Neural network, 1425
Neural progenitor cells (NPCs), 575, 1343
Neural protection, 913
Neural stem cell extract, 1439
Neural stem cells (NSCs), 705, 863, 1101, 1359, 1371, 1833, 1863, 1945, 1967, 2129
Neural transplantation, 1371
Neurodegenerative diseases, 195
Neurogenesis, 1453, 1853
Neuronal differentiation, 1177
Neuronal progenitor cells, 629
Neuropathic pain, 593
Neuroprotection, 125, 715, 883
Neurotrophic factor(s), 863, 893, 1115
Neurotrophin-3 (NT-3), 1425
Neutropenia, 17
Newborn, 1131
Newport Green (NG), 1777
Next-generation sequencing (NGS), 377
Niche, 1115
Nitric oxide (NO), 1879
Nonacute stroke, 1461
Nonhuman primate, 1331
Nonischemic cardiomyopathy (NICM), 1911
Nonresponders, 963
Notch, 353
Nucleus pulposus (NP), 1819
Numb, 353
Nurr-1 gene, 1177
(NZB × NZW) F1 mice, 1193
Olfactory ensheathing cells (OECs), 293
Olfactory mucosa, 141
Olig2 cDNA, 2129
Oligodendrocyte precursor cells (OPCs), 705
Oligodendrocyte progenitor cells (OPCs), 411, 2111
Oligodendrocytes, 1381
Oligodendrocyte-specific protein (OSP), 2129
Optogenetic stimulation, 1371
Organ donor, 1515
Osteoarthritis (OA), 937
Osteochondral repair, 1073
Osteogenesis, 1405, 1415
Osteogenic cell sheet, 1415
Oxidative stress, 55, 1967
Oxygenation, 531, 2269
Oxygen-glucose deprivation injury, 715
p53, 1025
p63, 353
Pain, 621
Pancreas, 1515
Pancreas preservation, 2269
Pancreas transplantation, 2041
Pancreatic islets, 1575
Paracrine effects, 829
Paracrine factor of transplanted liver cells, 1547
Paracrine factors, 735
Parkinson's disease (PD), 301, 1101, 1945, 2083
PD-1/PD-1L pathway, 327
Perfluorohydrocarbons, 2269
Pericapsular fibrosis, 1299
Peripheral blood stem cells (PBSCs), 283
Peripheral nerve regeneration, 183, 559
Peripheral nerve repair, 983
Perivascular clusters, 1359
Phosphate-buffered saline (PBS), 645
Phytohemagglutinin, 963
Pig pancreas, 531
Pigment epithelium-derived factor (PEDF), 1987
Pineal gland, 883
PIRCHE, 2041
Placenta, 1145, 2187
Plasma dyscrasia, 995
Plastic surgery, 951
Platelet activation, 1259
Platelet-derived growth factor (PDGF), 1893
Pluripotent stem cells (PSCs), 811, 849, 1007, 1945
Pluronic F68, 645
Poly(D, L-lactic acid) (PLA), 559
Polymerase chain reaction (PCR), 195
Polypyrrole/chitosan polymers, 1177
Porcine islets, 1763
Posttraumatic disorders, 797
Prairie vole, 783
Preconditioning, 2099
Preterm infant, 1381
Proliferation, 973, 1025, 1489
Pro-oligodendroblasts (proOLs), 2111
Psoriasis, 2063
Quality control, 2145
Rabbit, 1623
Radiation, 261
Radiotherapy side effects, 1723
Random clinical trial, 141
Rat diseased model, 549
Rat model, 301
Rats, 195
Rat sciatic nerve, 983
Reactive oxygen species (ROS), 55, 2063
Recombinant cells, 629
Refractory angina, 1701
Regeneration, 797, 937
Regenerative medicine, 201, 1287, 1723, 2213
Regenerative therapy, 951
Regulatory T cells (Tregs), 1057
Remnant liver, 1547
Repair, 1395
Reprogramming efficacy (RE), 1025
Retention, 1635
Retina, 1145
Retrograde approach, 1713
Rheumatoid arthritis (RA), 243, 1057
RIP-LCMV, 609
ROR2, 1561
Scar quality, 437
Schwann cells (SCs), 159, 183, 973
Sciatic nerve, 183, 1395
Sciatic nerve regeneration, 159
SDF-1–CXCR4 axis, 1247
Sebaceous glands (SGs), 2071
Secreted factor, 1101
Secretome, 829
Sedimentation, 645
Seeding density, 1539
Semiautomated method, 1777
Sensitization, 2041
Sensorimotor behavior, 1371
Serine1-histogranin (SHG), 629
Serotonin transporter, 301
Sertoli cells (SCs), 2027
Sheep, 615
Skin reconstruction, 2071
Skin substitution, 365
Social behavior, 783
Sol, 645
Somatosensory cortex, 1359
Species-specific tolerance, 327
Sphingosine-1-phosphate (S1P), 1265
Spinal cord, 2099
Spinal cord glioma, 2099
Spinal cord injury (SCI), 125, 141, 283, 293, 593, 1423, 1425, 1833, 1925, 2111
Spinal GABAergic neurons, 593
SPIO, 2199
Spontaneously hypertensive rat (SHR), 705
Stem cell factor (SCF), 729
Stem cell homing, 1265
Stem cells, 353, 1453, 1473, 1675, 1911
Stem cell therapy, 1689, 1701
Stem cell transplantation, 1085
Stemness potency assay, 1501
Stroke, 705, 849, 899, 1371, 1473, 2157
Stroke recovery, 729
Stroke serum priming, 1489
Stromal cell-derived factor (SDF), 1801
Stromal cell-derived factor-1α (SDF-1α), 365
Stromal-derived factor 1 (SDF-1), 1265
Stromal vascular fraction, 1623
Subventricular zone (SVZ), 1979
Superparamagnetic iron oxide (SPIO), 575
Superparamagnetic nanoparticles, 1787
Sural nerve, 1395
Systemic delivery, 1145
Systemic lupus erythematosus (SLE), 1, 1193
Systolic heart failure, 1911
T cells, 811
Temperature, 645
Temporal bone, 1405
Tendon, 109, 2199
Tendon healing, 463
Tendon injuries, 463
Tenocytes, 463
Therapeutic factor concentrate (TFC), 1623
Thermal stress, 2099
Thrombocytopenia, 261
Thromboinflammation, 1227
Tissue engineering, 1525, 2213
Tissue regeneration, 71
Tissue-specific tolerance, 327
Tolerance, 1207
Toll-like receptor 4 (TLR4), 1319
Transcription activator-like effector (TALE), 677
Transcriptome, 1159
Transduction efficacy, 1025
Transforming growth factor-β (TGF-β), 1145, 1439
Transgenic APP/PS1 mice, 1853
Transplant, 1343
Transplantation, 411, 549, 929, 1101, 1237, 1277, 1359, 1405, 1423, 1635, 1863, 2003, 2111, 2173
Transposon, 783
Traumatic brain injury (TBI), 797, 1863
Traumatic brain injury rat model, 1085
Tribbles homolog 3 (trib3), 55
Trophic effect, 183
Trophic factor, 425
Tumor stem cell, 2099
Type 1 diabetes (T1D), 609
Type 1 diabetes mellitus, 1893
Ultrasmall superparamagnetic iron oxide (USPIO) nanoparticles, 1085
Umbilical cord (UC), 217, 1287, 1591, 1713
Umbilical cord blood, 1277, 1925
Umbilical cord blood transplantation, 1259
Urinary epithelial cells, 2221
Urine-derived stem cells (USCs), 1987
Urodynamics, 125
Uterus, 1665
Vascular development, 2187
Vascular graft-versus-host disease (GVHD), 2051
Vascularization, 365
VEGF, 2173
Vehicle, 645
Ventral mesencephalon, 2083
Vertebral body, 1819
Virus-induced diabetes, 609
Volume fraction, 645
Voluntary exercise, 1979
Wharton's jelly epithelial progenitor cells (EPCs) and mesenchymal stem cells (MSCs), 715
Wheel running, 1979
Whole blood model, 503
Wound healing, 437
Xenograft, 293, 301
Xenotransplantation, 1299, 1763, 2027
Zinc-specific fluorescent dye, 1777
